Finer Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Finer Wealth Management's BMY Position: Q3 2026 in Review
Finer Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q3 2026, selling an estimated $34.1K and leaving 4,467 shares worth $279K. The position accounts for 0.11% of the portfolio, ranked #79.
Finer Wealth Management first reported a position in BMY in Q4 2021 and has held it in 20 quarters since. The position peaked at $3.73M in Q2 2022. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Finer Wealth Management held 4,467 shares of Bristol-Myers Squibb worth $279K as of Q3 2026.
- Finer Wealth Management sold 540 Bristol-Myers Squibb shares in Q3 2026, an estimated $34.1K.
- Bristol-Myers Squibb made up 0.11% of Finer Wealth Management's portfolio in Q3 2026, its #79 holding.
- Finer Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 20 quarters since.
- Finer Wealth Management's Bristol-Myers Squibb position peaked at $3.73M in Q2 2022.
- 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Finer Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.